-
Christele Felix’s Lupus Story: “This Is the Best I’ve Ever Been”
by Maria Lissandrello on February 3, 2023 at 4:10 pm
Christele Felix doesn’t apologize for having lupus. She doesn’t run from it either. Instead, she rises to the challenge each day and […]
-
Alzheimer’s as an autoimmune disease: ‘We will need competence in the area of immunology’
by Rob Volansky on February 3, 2023 at 3:00 pm
What if Alzheimer’s disease, a neurological disorder that has confounded researchers since its identification in 1907, were not a brain […]
-
Amgen’s acquisition of Horizon could have ‘downstream effects’ in rheumatology
by Rob Volansky on February 2, 2023 at 9:30 pm
The recent acquisition of Horizon Therapeutics by Amgen continues a trend in medical finance that may have implications for both […]
-
CDC Releases COVID-19 Action Plan for People with Weakened Immune Systems
by Kelsey Kloss on February 2, 2023 at 7:34 pm
The plan outlines a list of COVID prevention measures that you're likely already taking if you're high-risk for severe COVID — and you […]
-
What People Ask Me About Living with Rheumatoid Arthritis
by Eileen Davidson on February 2, 2023 at 2:42 pm
In recognition of Rheumatoid Arthritis Awareness Day, patient advocate Eileen Davidson shares answers to the most common (and bizarre) […]
-
Smaller dose, new regimen recommended for pexidartinib in TGCT after post-marketing data
by Jason Laday on February 2, 2023 at 10:30 am
A reduced dosage and updated regimen are now available for the oral small molecule pexidartinib in the treatment of adults with symptomatic […]
-
FDA grants Orphan Drug Designation to belimumab for systemic sclerosis
on February 1, 2023 at 6:27 pm
The FDA has granted Orphan Drug Designation to belimumab, a B-cell inhibiting monoclonal antibody, for the potential treatment of systemic […]
-
Raven Miller’s Rheumatoid Arthritis Story: “I Found My Motivation”
by Maria Lissandrello on February 1, 2023 at 3:30 pm
Raven Miller, a single mom and creator of Raven Takes RA, shares her journey with rheumatoid arthritis, and how she finally reached a place […]
-
Lupus education, support systems necessary to meet needs of African American youth
by Erich Martin on February 1, 2023 at 10:30 am
There is an unmet need among African American youth for more plentiful education and resources regarding lupus, according to data published […]
-
ACR urges CMS to revise policy excluding copay assistance from counting toward deductible
on January 31, 2023 at 7:02 pm
The American College of Rheumatology is urging CMS to reconsider its current policy of allowing insurers to exclude copay assistance […]
-
Study Suggests Disconnect Between Doctors and Patients Over Psoriatic Arthritis Fatigue
by Barbara Brody on January 31, 2023 at 3:33 pm
New research suggests that doctors often underestimate the severity of fatigue in people with psoriatic arthritis, despite it remaining a […]
-
Inhalable agents in workplace ‘important’ triggers for rheumatoid arthritis
by Erich Martin on January 31, 2023 at 10:30 am
Inhalable substances associated with occupational settings may act as “important” environmental triggers for developing rheumatoid […]
-
Celltrion submits application for subcutaneous infliximab in inflammatory bowel disease
by Erich Martin on January 30, 2023 at 9:35 pm
Celltrion has submitted a biologics license application to the FDA for the consideration of a subcutaneous formulation of infliximab in the […]
-
A Guide to Setting Boundaries if You’re a People-Pleaser
by Kelsey Kloss on January 30, 2023 at 7:07 pm
Saying no isn’t always easy, but with practice, it can become a habit. The post A Guide to Setting Boundaries if You’re a […]
-
MRI-based grading may help determine which knees suitable for osteoarthritis treatment
by Erich Martin on January 30, 2023 at 10:30 am
Using MRIs to grade articular pathologies can help identify knees suitable for osteoarthritis trials, as well as those without cartilage […]
Categories What's New
March 24, 2020